Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ARDILLON, Laurent
SENIORHEMO, NCT05218772: Objective and Perceived Health Status of Elderly People With Moderate or Severe Haemophilia in France: an Ancillary Study of the FranceCoag Registry	Recruiting	N/A	612	Europe	Questionnaires	Assistance Publique Hopitaux De Marseille	Moderate or Serious Haemophilia	06/23	12/23
GENDYSFIB, NCT05233384: Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia	Active, not recruiting	N/A	70	Europe	Blood test	University Hospital, Clermont-Ferrand	Hereditary Dysfibrinogenemia	05/24	12/24
WILL MANAGE, NCT06651255: Algorithm-based Management to Reduce the Recurrence of Gastrointestinal Bleeding and Severe Epistaxis in Von Willebrand Disease	Not yet recruiting	N/A	66	Europe	Optimized management, Standard of care management	University Hospital, Lille	Von Willebrand Disease (VWD)	01/34	12/34
ESCORT-HU Extension, NCT04707235: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study	Active, not recruiting	N/A	2093	Europe, RoW	Hydroxycarbamide, Siklos, Hydroxyurea	Theravia, International Clinical Trials Association	Sickle Cell Disease	08/25	08/25
GIDEMHA, NCT05628558: Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A	Recruiting	N/A	800	Europe	Desmopressin, DDAVP	Groupe Maladies hémorragiques de Bretagne	Hemophilia A, Mild, Desmopressin, Factor VIII	12/22	04/23
Valentin, Jean Baptiste
ESCORT-HU Extension, NCT04707235: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study	Active, not recruiting	N/A	2093	Europe, RoW	Hydroxycarbamide, Siklos, Hydroxyurea	Theravia, International Clinical Trials Association	Sickle Cell Disease	08/25	08/25